Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Seth M Steinberg

Showing results (351-360 of 481) with videos related to

Pageof 49
Sort By:
The Lancet. Haematology|April 3, 2023
Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trialChristopher Melani, Kennichi Dowdell, Stefania Pittaluga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II StudyMark N Polizzotto, Thomas S Uldrick, Kathleen M Wyvill, et al.
Molecular Interventions|January 18, 2008
Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practiceRobert Kinders, Ralph E Parchment, Jay Ji, et al.
Clinical Colorectal Cancer|April 12, 2015
A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal CancerKhanh Do, Liang Cao, Zhigang Kang, et al.
Oncotarget|August 4, 2016
Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trialChristopher R Heery, Ravi A Madan, Mark N Stein, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 27, 2019
Disease-free interval and tumor functional status can be used to select patients for resection/ablation of liver metastases from adrenocortical carcinoma: insights from a multi-institutional studyReed I Ayabe, Raja R Narayan, Samantha M Ruff, et al.
The Oncologist|March 26, 2017
A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi SarcomaThomas S Uldrick, Priscila H Gonçalves, Kathleen M Wyvill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2020
Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell LeukemiaDai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2007
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockadeStephanie G Downey, Jacob A Klapper, Franz O Smith, et al.
Translational Lung Cancer Research|August 2, 2019
A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancerTakefumi Komiya, Regan M Memmott, Gideon M Blumenthal, et al.
Pageof 49

Showing results (351-360 of 481) with videos related to

Sort By:
Pageof 49
The Lancet. Haematology|April 3, 2023
Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trialChristopher Melani, Kennichi Dowdell, Stefania Pittaluga, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II StudyMark N Polizzotto, Thomas S Uldrick, Kathleen M Wyvill, et al.
Molecular Interventions|January 18, 2008
Phase 0 clinical trials in cancer drug development: from FDA guidance to clinical practiceRobert Kinders, Ralph E Parchment, Jay Ji, et al.
Clinical Colorectal Cancer|April 12, 2015
A Phase II Study of Sorafenib Combined With Cetuximab in EGFR-Expressing, KRAS-Mutated Metastatic Colorectal CancerKhanh Do, Liang Cao, Zhigang Kang, et al.
Oncotarget|August 4, 2016
Samarium-153-EDTMP (Quadramet®) with or without vaccine in metastatic castration-resistant prostate cancer: A randomized Phase 2 trialChristopher R Heery, Ravi A Madan, Mark N Stein, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|August 27, 2019
Disease-free interval and tumor functional status can be used to select patients for resection/ablation of liver metastases from adrenocortical carcinoma: insights from a multi-institutional studyReed I Ayabe, Raja R Narayan, Samantha M Ruff, et al.
The Oncologist|March 26, 2017
A Phase Ib Study of Sorafenib (BAY 43-9006) in Patients with Kaposi SarcomaThomas S Uldrick, Priscila H Gonçalves, Kathleen M Wyvill, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 29, 2020
Randomized Phase II Study of First-Line Cladribine With Concurrent or Delayed Rituximab in Patients With Hairy Cell LeukemiaDai Chihara, Evgeny Arons, Maryalice Stetler-Stevenson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2007
Prognostic factors related to clinical response in patients with metastatic melanoma treated by CTL-associated antigen-4 blockadeStephanie G Downey, Jacob A Klapper, Franz O Smith, et al.
Translational Lung Cancer Research|August 2, 2019
A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancerTakefumi Komiya, Regan M Memmott, Gideon M Blumenthal, et al.
Pageof 49